Skip to main content

AusPAR: Eligard

Australian Public Assessment Report
Device/Product Name
Eligard (Eligard 6 month)
Active ingredients
Leuprorelin acetate
AusPAR Date
Published
Submission Number
PM-2021-01406-1-5
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site